The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Budesonide-Global Market Insights and Sales Trends 2025
Synopsis
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
The global Budesonide market size is expected to reach US$ 10250 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Budesonide in various end use industries. The expanding demands from the Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment and Others, are propelling Budesonide market. Injectable Suspension, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Aerosols segment is estimated at % CAGR for the next seven-year period.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Budesonide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Budesonide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Budesonide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Budesonide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Budesonide covered in this report include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc.
The global Budesonide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Global Budesonide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Budesonide market, Segment by Type:
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Global Budesonide market, by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
The global Budesonide market size is expected to reach US$ 10250 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Budesonide in various end use industries. The expanding demands from the Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment and Others, are propelling Budesonide market. Injectable Suspension, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Aerosols segment is estimated at % CAGR for the next seven-year period.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Budesonide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Budesonide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Budesonide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Budesonide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Budesonide covered in this report include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc.
The global Budesonide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Global Budesonide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Budesonide market, Segment by Type:
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Global Budesonide market, by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Budesonide Market Overview
1.1 Budesonide Product Overview
1.2 Budesonide Market Segment by Type
1.2.1 Injectable Suspension
1.2.2 Aerosols
1.2.3 Inhalation Powder
1.2.4 Tablet and Capsule
1.3 Global Budesonide Market Size by Type
1.3.1 Global Budesonide Market Size Overview by Type (2018-2029)
1.3.2 Global Budesonide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Budesonide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Budesonide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Budesonide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Budesonide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Budesonide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Budesonide Sales Breakdown by Type (2018-2023)
2 Global Budesonide Market Competition by Company
2.1 Global Top Players by Budesonide Sales (2018-2023)
2.2 Global Top Players by Budesonide Revenue (2018-2023)
2.3 Global Top Players by Budesonide Price (2018-2023)
2.4 Global Top Manufacturers Budesonide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Budesonide Market Competitive Situation and Trends
2.5.1 Budesonide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Budesonide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Budesonide as of 2022)
2.7 Date of Key Manufacturers Enter into Budesonide Market
2.8 Key Manufacturers Budesonide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Budesonide Status and Outlook by Region
3.1 Global Budesonide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Budesonide Historic Market Size by Region
3.2.1 Global Budesonide Sales in Volume by Region (2018-2023)
3.2.2 Global Budesonide Sales in Value by Region (2018-2023)
3.2.3 Global Budesonide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Budesonide Forecasted Market Size by Region
3.3.1 Global Budesonide Sales in Volume by Region (2024-2029)
3.3.2 Global Budesonide Sales in Value by Region (2024-2029)
3.3.3 Global Budesonide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Budesonide by Application
4.1 Budesonide Market Segment by Application
4.1.1 Respiratory Disease Treatment
4.1.2 Nose Disease Treatment
4.1.3 Inflammatory Bowel Disease Treatment
4.1.4 Others
4.2 Global Budesonide Market Size by Application
4.2.1 Global Budesonide Market Size Overview by Application (2018-2029)
4.2.2 Global Budesonide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Budesonide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Budesonide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Budesonide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Budesonide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Budesonide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Budesonide Sales Breakdown by Application (2018-2023)
5 North America Budesonide by Country
5.1 North America Budesonide Historic Market Size by Country
5.1.1 North America Budesonide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Budesonide Sales in Volume by Country (2018-2023)
5.1.3 North America Budesonide Sales in Value by Country (2018-2023)
5.2 North America Budesonide Forecasted Market Size by Country
5.2.1 North America Budesonide Sales in Volume by Country (2024-2029)
5.2.2 North America Budesonide Sales in Value by Country (2024-2029)
6 Europe Budesonide by Country
6.1 Europe Budesonide Historic Market Size by Country
6.1.1 Europe Budesonide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Budesonide Sales in Volume by Country (2018-2023)
6.1.3 Europe Budesonide Sales in Value by Country (2018-2023)
6.2 Europe Budesonide Forecasted Market Size by Country
6.2.1 Europe Budesonide Sales in Volume by Country (2024-2029)
6.2.2 Europe Budesonide Sales in Value by Country (2024-2029)
7 Asia-Pacific Budesonide by Region
7.1 Asia-Pacific Budesonide Historic Market Size by Region
7.1.1 Asia-Pacific Budesonide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Budesonide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Budesonide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Budesonide Forecasted Market Size by Region
7.2.1 Asia-Pacific Budesonide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Budesonide Sales in Value by Region (2024-2029)
8 Latin America Budesonide by Country
8.1 Latin America Budesonide Historic Market Size by Country
8.1.1 Latin America Budesonide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Budesonide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Budesonide Sales in Value by Country (2018-2023)
8.2 Latin America Budesonide Forecasted Market Size by Country
8.2.1 Latin America Budesonide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Budesonide Sales in Value by Country (2024-2029)
9 Middle East and Africa Budesonide by Country
9.1 Middle East and Africa Budesonide Historic Market Size by Country
9.1.1 Middle East and Africa Budesonide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Budesonide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Budesonide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Budesonide Forecasted Market Size by Country
9.2.1 Middle East and Africa Budesonide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Budesonide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Budesonide Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Budesonide Products Offered
10.2.5 Teva Recent Development
10.3 Mylan
10.3.1 Mylan Company Information
10.3.2 Mylan Introduction and Business Overview
10.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan Budesonide Products Offered
10.3.5 Mylan Recent Development
10.4 Sandoz
10.4.1 Sandoz Company Information
10.4.2 Sandoz Introduction and Business Overview
10.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sandoz Budesonide Products Offered
10.4.5 Sandoz Recent Development
10.5 Cosmo Pharmaceuticals
10.5.1 Cosmo Pharmaceuticals Company Information
10.5.2 Cosmo Pharmaceuticals Introduction and Business Overview
10.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cosmo Pharmaceuticals Budesonide Products Offered
10.5.5 Cosmo Pharmaceuticals Recent Development
10.6 Salix
10.6.1 Salix Company Information
10.6.2 Salix Introduction and Business Overview
10.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Salix Budesonide Products Offered
10.6.5 Salix Recent Development
10.7 Chiesi Farmaceutici
10.7.1 Chiesi Farmaceutici Company Information
10.7.2 Chiesi Farmaceutici Introduction and Business Overview
10.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Chiesi Farmaceutici Budesonide Products Offered
10.7.5 Chiesi Farmaceutici Recent Development
10.8 Orion Corporation
10.8.1 Orion Corporation Company Information
10.8.2 Orion Corporation Introduction and Business Overview
10.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Orion Corporation Budesonide Products Offered
10.8.5 Orion Corporation Recent Development
10.9 Cipla
10.9.1 Cipla Company Information
10.9.2 Cipla Introduction and Business Overview
10.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Cipla Budesonide Products Offered
10.9.5 Cipla Recent Development
10.10 Synmosa Biopharma
10.10.1 Synmosa Biopharma Company Information
10.10.2 Synmosa Biopharma Introduction and Business Overview
10.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Synmosa Biopharma Budesonide Products Offered
10.10.5 Synmosa Biopharma Recent Development
10.11 Lunan Better Pharma
10.11.1 Lunan Better Pharma Company Information
10.11.2 Lunan Better Pharma Introduction and Business Overview
10.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Lunan Better Pharma Budesonide Products Offered
10.11.5 Lunan Better Pharma Recent Development
10.12 Shanghai Sine Promod
10.12.1 Shanghai Sine Promod Company Information
10.12.2 Shanghai Sine Promod Introduction and Business Overview
10.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Shanghai Sine Promod Budesonide Products Offered
10.12.5 Shanghai Sine Promod Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Budesonide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Budesonide Industrial Chain Analysis
11.4 Budesonide Market Dynamics
11.4.1 Budesonide Industry Trends
11.4.2 Budesonide Market Drivers
11.4.3 Budesonide Market Challenges
11.4.4 Budesonide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Budesonide Distributors
12.3 Budesonide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
